Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Sponsors: Hebei Medical University Third Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research